| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |